Joseph Rucker
Company: Integral Molecular
Job title: VP, Research and Development
Seminars:
Identification & Preclinical Characterization of CTIM-76, a CLDN6 x CD3 Bispecific Antibody 1:15 pm
Isolation of CLDN6 antibodies with exquisite specificity for CLDN6 over other members of the CLDN family Molecular engineering and in vitro characterization of CTIM-76 Preclinical data supporting CTIM-76 entry into clinical trials for ovarian cancer and other advanced solid tumorsRead more
day: Conference Day 1